Orthopedic Company Comes Under SEC Scrutiny
Orthopedic products company ReGen Biologics Inc. said Monday that it has received a letter from the U.S. Securities and Exchange Commission's Division of Enforcement requesting information regarding the company's stock options-granting...To view the full article, register now.
Already a subscriber? Click here to view full article